Acta Med. 2019, 62: 99-104

Monocyte to Lymphocyte Ratio, Neutrophil to Lymphocyte Ratio, and Red Cell Distribution Width are the Associates with Gouty Arthritis

Cengiz Kadiyorana, Orhan Zenginb, Hilal Akay Cizmeciogluc, Abdurrahman Tufand, Orhan Kucuksahine, Medine Cumhur Curef, Erkan Cureg, Adem Kucukh, Mehmet Akif Ozturkd

aDepartment of Radiology, Necmettin Erbakan University, Konya, Turkey
bDepartment of Rheumatology, Adiyaman Training and Research Hospital, Adiyaman, Turkey
cDepartment of Internal Medicine, Necmettin Erbakan University, Konya, Turkey
dDivision of Rheumatology, Department of Internal Medicine, Gazi University Faculty of Medicine, Ankara, Turkey
eDivision of Rheumatology, Department of Internal Medicine, Ankara Liv Hospital, Kavaklidere, Ankara, Turkey
fDepartment of Biochemistry, Sadik Ahmet Hospital, Istanbul, Turkey
gDepartment of Internal Medicine, Ota&Jinemed Hospital, Istanbul, Turkey
hDivision of Rheumatology, Department of Internal Medicine, Necmettin Erbakan University, Konya, Turkey

Received April 4, 2019
Accepted July 18, 2019


1. Mirmiran R, Bush T, Cerra MM, et al. Joint Clinical Consensus Statement of the American College of Foot and Ankle Surgeons® and the American Association of Nurse Practitioners®: Etiology, Diagnosis, and Treatment Consensus for Gouty Arthritis of the Foot and Ankle. J Foot Ankle Surg 2018; 57: 1207–7. <>
2. Ragab G, Elshahaly M, Bardin T. Gout: An old disease in new perspective – A review. J Adv Res 2017; 8: 495–511. <> <PubMed>
3. Terkeltaub R. What makes gouty inflammation so variable? BMC Med 2017; 15: 158. <> <PubMed>
4. Zamudio-Cuevas Y, Hernandez-Díaz C, Pineda C, et al. Molecular basis of oxidative stress in gouty arthropathy. Clin Rheumatol 2015; 34: 1667–72. <>
5. Schett G, Schauer C, Hoffmann M, et al. Why does the gout attack stop? A roadmap for the immune pathogenesis of gout. RMD Open 2015; 1: e000046. <> <PubMed>
6. Pope RM, Tschopp J. The role of interleukin-1 and the inflammasome in gout: implications for therapy. Arthritis Rheum 2007; 56: 3183–8. <>
7. Joosten LA, Netea MG, Mylona E, et al. Engagement of fatty acids with Toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum 2010; 62: 3237–48. <> <PubMed>
8. Cronstein BN, Sunkureddi P. Mechanistic aspects of inflammation and clinical management of inflammation in acute gouty arthritis. J Clin Rheumatol 2013; 19: 19–29. <> <PubMed>
9. Ren K, Yin Y, He F, et al. Prognostic role of derived neutrophil-to-lymphocyte ratio in surgical triple-negative breast cancer. Cancer Manag Res 2018; 10: 4891–8. <> <PubMed>
10. Cure MC, Cure E, Kirbas A, et al. The effects of Gilbert’s syndrome on the mean platelet volume and other hematological parameters. Blood Coagul Fibrinolysis 2013; 24: 484–8. <>
11. Lin J, Zhang W, Huang Y, et al. Sarcopenia is associated with the neutrophil/ lymphocyte and platelet/lymphocyte ratios in operable gastric cancer patients: a prospective study. Cancer Manag Res 2018; 10: 4935–44. <> <PubMed>
12. Nam KW, Kwon HM, Jeong HY, et al. High neutrophil to lymphocyte ratios predict intracranial atherosclerosis in a healthy population. Atherosclerosis 2018; 269: 117–21. <>
13. Zhu Z, Xu L, Zhuang L, et al. Role of monocyte-to-lymphocyte ratio in predicting sorafenib response in patients with advanced hepatocellular carcinoma. Onco Targets Ther 2018; 11: 6731–40. <> <PubMed>
14. Cumhur Cure M, Cure E, Yuce S, et al. Mean platelet volume and vitamin D level. Ann Lab Med 2014; 34: 98–103. <> <PubMed>
15. den Harder AM, de Jong PA, de Groot MCH, et al. Commonly available hematological biomarkers are associated with the extent of coronary calcifications. Atherosclerosis. 2018; 275: 166–73. <>
16. Khanna D, Fitzgerald JD, Khanna PP, et al. American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012; 64: 1431–46. <> <PubMed>
17. Khanna D, Khanna PP, Fitzgerald JD, et al. American College of Rheumatology. 2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1447–61. <> <PubMed>
18. Litao MK, Kamat D. Erythrocyte sedimentation rate and C-reactive protein: how best to use them in clinical practice. Pediatr Ann 2014; 43: 417–20. <>
19. Badulescu M, Macovei L, Rezuş E. Acute gout attack with normal serum uric acid levels. Rev Med Chir Soc Med Nat Iasi 2014; 118: 942–5.
20. Robinson PC. Gout – An update of aetiology, genetics, co-morbidities and management. Maturitas 2018; 118: 67–73. <>
21. Maruhashi T, Hisatome I, Kihara Y, et al. Hyperuricemia and endothelial function: From molecular background to clinical perspectives. Atherosclerosis 2018; 278: 226–31. <>
22. Tomiyama H, Shiina K, Vlachopoulos C, et al. Involvement of Arterial Stiffness and Inflammation in Hyperuricemia-Related Development of Hypertension. Hypertension 2018; 72: 739–45. <>
23. Baey C, Yang J, Ronchese F, Harper JL. Hyperuricaemic UrahPlt2/Plt2 mice show altered T cell proliferation and defective tumor immunity after local immunotherapy with Poly I:C. PLoS One 2018; 13: e0206827. <> <PubMed>
24. Crişan TO, Cleophas MCP, Novakovic B, et al. Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway. Proc Natl Acad Sci U S A 2017; 114: 5485–90. <> <PubMed>
25. Crișan TO, Cleophas MC, Oosting M, et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via inhibition of IL-1Ra. Ann Rheum Dis 2016; 75: 755–62. <>
26. Harre U, Derer A, Schorn C, et al. T cells as key players for bone destruction in gouty arthritis? Arthritis Res Ther 2011; 13: 135. <> <PubMed>
27. Martin WJ, Shaw O, Liu X, et al. Monosodium urate monohydrate crystal-recruited noninflammatory monocytes differentiate into M1-like proinflammatory macrophages in a peritoneal murine model of gout. Arthritis Rheum 2011; 63: 1322–32. <>
28. Ley K, Miller YI, Hedrick CC. Monocyte and macrophage dynamics during atherogenesis. Arterioscler Thromb Vasc Biol 2011; 31: 1506–16. <> <PubMed>
29. Gravani F, Papadaki I, Antypa E, et al. Subclinical atherosclerosis and impaired bone health in patients with primary Sjogren’s syndrome: prevalence, clinical and laboratory associations. Arthritis Res Ther 2015; 17: 99. <> <PubMed>
30. Fan Z, Li Y, Ji H, Jian X. Prognostic utility of the combination of monocyte-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with NSTEMI after primary percutaneous coronary intervention: a retrospective cohort study. BMJ Open 2018; 8: e023459. <> <PubMed>
31. Ji H, Li Y, Fan Z, et al. Monocyte/lymphocyte ratio predicts the severity of coronary artery disease: a syntax score assessment. BMC Cardiovasc Disord 2017; 17: 90. <> <PubMed>
32. Mitroulis I, Kambas K, Chrysanthopoulou A, et al. Neutrophil extracellular trap formation is associated with IL-1β and autophagy-related signaling in gout. PLoS One 2011; 6: e29318. <> <PubMed>
33. Schorn C, Janko C, Krenn V, et al. Bonding the foe – NETting neutrophils immobilize the pro-inflammatory monosodium urate crystals. Front Immunol 2012; 3: 376.
34. Li X, Ji Y, Kang J, Fang N. Association between blood neutrophil- to-lymphocyte ratio and severity of coronary artery disease: Evidence from 17 observational studies involving 7017 cases. Medicine (Baltimore) 2018; 97: e12432. <> <PubMed>
35. Diakos CI, Charles KA, McMillan DC, et al. Cancer-related inflammation and treatment effectiveness. Lancet Oncol 2014; 15: e493–503. <>
36. Hartman ES, Brindley EC, Papoin J, et al. Increased Reactive Oxygen Species and Cell Cycle Defects Contribute to Anemia in the RASA3 Mutant Mouse Model scat. Front Physiol 2018; 9: 689. <> <PubMed>
37. Kanda J, Mizumoto C, Kawabata H, et al. Serum hepcidin level and erythropoietic activity after hematopoietic stem cell transplantation. Haematologica 2008; 93: 1550–4. <>
38. Kroot JJ, Tjalsma H, Fleming RE, et al. Hepcidin in human iron disorders: diagnostic implications. Clin Chem 2011; 57: 1650–69. <>
39. Nam JS, Ahn CW, Kang S, et al. Red Blood Cell Distribution Width Is Associated with Carotid Atherosclerosis in People with Type 2 Diabetes. J Diabetes Res 2018; 2018: 1792760. <> <PubMed>
40. Conway R, Murphy CL, Madigan A, et al. Increased platelet reactivity as measured by plasma glycoprotein VI in gout. Platelets 2018; 29: 821–6. <>
front cover

ISSN 1211-4286 (Print) ISSN 1805-9694 (Online)